Shengtao Tian

Shengtao Tian

UNVERIFIED PROFILE

Are you Shengtao Tian?   Register this Author

Register author
Shengtao Tian

Shengtao Tian

Publications by authors named "Shengtao Tian"

4Publications

19Reads

46Profile Views

1PubMed Central Citations

Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.

Cancer Manag Res 2019 3;11:4065-4073. Epub 2019 May 3.

Department of Interventional Radiology, The First Medical Center of PLA General Hospital, Beijing, 100853, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S195485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504701PMC
May 2019

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma.

Onco Targets Ther 2018 31;11:3257-3265. Epub 2018 May 31.

Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S165000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987756PMC
May 2018

MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.

Oncotarget 2018 Mar 11;9(20):15252-15265. Epub 2018 Jan 11.

Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Cancer Research Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300070, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880601PMC
March 2018

What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis.

Oncotarget 2017 Nov 10;8(59):100508-100523. Epub 2017 Aug 10.

Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300070, China.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/20119
Publisher Site
http://dx.doi.org/10.18632/oncotarget.20119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725039PMC
November 2017